or Try an Advanced Search...

    ETF Components for LABD - Direxion Daily S&P Biotech Bear 3X Shares


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    EXEL F -0.24 1.91
    BMRN F -4.66 1.89
    BLUE F -2.80 1.87
    VRTX C 0.38 1.84
    SAGE F 2.03 1.80
    UTHR B 0.20 1.78
    REGN C -0.89 1.77
    AMGN B -0.95 1.75
    ALNY C 0.37 1.73
    EXAS F -2.47 1.73
    ABBV D 0.05 1.72
    ACAD F -1.98 1.68
    SRPT C -0.89 1.66
    BIIB C -2.58 1.65
    IONS F -6.07 1.64
    GILD F 1.00 1.64
    NBIX C -0.99 1.62
    BPMC B -0.65 1.61
    INCY F -0.44 1.51
    RARE F 3.14 1.49
    MRNA C 2.46 1.47
    LGND B -0.02 1.46
    ARWR F -0.64 1.45
    BHVN F 1.55 1.42
    PTCT C 0.68 1.40
    FOLD F -2.23 1.38
    AGIO C -0.37 1.37
    APLS F -2.18 1.24
    ALKS F 0.41 1.21
    MYGN A -0.69 1.08
    NTRA B 0.62 1.08
    IOVA D -2.39 1.07
    FGEN F 0.85 1.05
    RGNX F -1.39 1.05
    DCPH A 0.00 1.01
    CHRS F 0.46 0.99
    EBS C -6.04 0.96
    CDNA B -0.74 0.93
    HRTX C 5.67 0.84
    INSM D 0.44 0.81
    KPTI F 0.44 0.79
    ESPR D 6.30 0.79
    ALLK F 9.28 0.76
    IRWD F -0.61 0.75
    VCYT D 0.51 0.72
    HALO B -0.72 0.71
    FATE D -0.24 0.67
    EDIT F -1.33 0.66
    PBYI D -4.37 0.65
    MDGL D 1.54 0.59
    TGTX C -1.07 0.55
    ADVM F -6.06 0.55
    ALLO F 0.67 0.54
    CPRX C -1.38 0.53
    ANAB C -0.86 0.53
    XNCR C 4.09 0.49
    SGMO F 5.12 0.48
    ENTA D -2.17 0.47
    EGRX F 0.27 0.42
    GTHX B -0.85 0.42
    ATRA F -1.56 0.41
    VKTX C -9.96 0.38
    ANIK C -0.92 0.37
    VNDA B 3.12 0.35
    OPK C -3.33 0.35
    VCEL B -3.90 0.34
    TVTX F -2.35 0.33
    KOD D -2.67 0.29
    BBIO D 2.37 0.29
    NTLA F -0.46 0.29
    PGEN F -1.74 0.29
    DNLI F -1.49 0.28
    KRYS D 0.54 0.28
    GOSS F -1.91 0.27
    VYGR D -0.82 0.26
    MGNX F 8.28 0.25
    ALEC F -2.04 0.25
    CYTK D -1.21 0.25
    DVAX F 0.36 0.24
    YMAB D -2.30 0.24

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Biotechnology Medicine Cancer Life Sciences Clinical Development Biology Chemical Compounds Inflammation Clinical Medicine Disease Immune System Immunology S&P 500 Cholesterol Genetics Infectious Diseases Monoclonal Antibody Nasdaq 100 Organ Systems
    Industries: Biotechnology Drug Manufacturers - Specialty & Generic Drug Manufacturers - Major Diagnostics & Research

    Recent News for Direxion Daily S&P Biotech Bear 3X Shares & its Holdings

    Date Stock Title
    May 16 MRNA Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
    May 16 HALO Here's Why Halozyme Therapeutics (HALO) is a Strong Growth Stock
    May 16 IOVA 4 Small-Cap Value Stocks That Could Go Parabolic
    May 16 BLUE Is Bluebird Bio Stock a Buy?
    May 16 BIIB Biogen and Ionis drop ALS candidate after trial setback
    May 16 IONS Biogen and Ionis drop ALS candidate after trial setback
    May 16 FATE Alibaba To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Thursday
    May 16 IONS REFILE-UPDATE 2-Biogen, Ionis to discontinue development of experimental ALS drug
    May 16 BIIB REFILE-UPDATE 2-Biogen, Ionis to discontinue development of experimental ALS drug
    May 16 BIIB Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
    May 16 IONS Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
    May 16 BIIB Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
    May 16 IONS Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
    May 16 REGN These 2 No-Brainer Growth Stocks Are Breaking New Ground
    May 16 IONS Ionis announces positive topline results from Phase 1/2a trial of ION582 for Angelman syndrome
    May 16 VYGR Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer’s Disease
    May 16 ARWR ARWR: Summer Webinar Series to Highlight Development Pipeline…
    May 16 VNDA Vanda Pharmaceuticals reports positive data from motion sickness trial
    May 16 BMRN Third Point top buy and sells in Q1
    May 16 LGND Insider Sale: President & Chief Operating Officer Matthew Korenberg Sells Shares of Ligand ...
    The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the performance of the S&P Biotechnology Select Industry Index. The index is provided by Standard & Poor's and includes domestic companies from the biotechnology industry. The fund normally creates short positions by investing at least 80% of its assets in: swap agreements; options on securities and indices; forward contracts; short positions; reverse repurchase agreements; ETFs; and other financial instruments that, in combination, provide inverse leveraged and unleveraged exposure to the S&P Biotechnology Select Industry Index ("index"). It is non-diversified.
    Exchange Traded Fund ETF Exchange Traded Funds Biotechnology Leveraged ETF Ultra ETF S&P 500 Index CBOE Inverse ETF Bear Market ETF Repurchase Agreement Financial Regulation Forward Contract
    Back to the Main LABD Page...